Literature DB >> 15165931

Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project).

Dwayne S G Conway1, Gregory Y H Lip.   

Abstract

In a multiethnic cohort of 388 patients admitted with symptomatic peripheral artery disease, atrial fibrillation was associated with emergency admission and increased mortality. Despite a greater prevalence of hypertension and diabetes in Afro-Caribbeans and diabetes in Indo-Asians, no significant differences were found in atrial fibrillation prevalence or mortality among different ethnic groups. Patients with symptomatic peripheral artery disease and atrial fibrillation should be regarded as "high risk" and managed with optimal medical therapy, including appropriate thromboprophylaxis and close follow-up.

Entities:  

Mesh:

Year:  2004        PMID: 15165931     DOI: 10.1016/j.amjcard.2004.02.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials.

Authors:  Andrew B Hughey; Xiaokui Gu; Brian Haymart; Eva Kline-Rogers; Steve Almany; Jay Kozlowski; Dennis Besley; Gregory D Krol; Syed Ahsan; Scott Kaatz; James B Froehlich; Geoffrey D Barnes
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

Review 2.  Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.

Authors:  Shadi Yaghi; Hooman Kamel
Journal:  Stroke       Date:  2017-09-15       Impact factor: 7.914

Review 3.  Stroke Prevention in Atrial Fibrillation.

Authors:  Michael Katsnelson; Sebastian Koch; Tatjana Rundek
Journal:  J Atr Fibrillation       Date:  2010-10-22

Review 4.  Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.

Authors:  Abhishek Maan; Amir Y Shaikh; Moussa Mansour; Jeremy N Ruskin; E Kevin Heist
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 5.  AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

Authors:  Nasir Shariff; Abdul Aleem; Mukesh Singh; Yuan Z Li; Stacey J Smith
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 6.  Antithrombotic treatment for peripheral arterial disease.

Authors:  Daniel G Hackam; John W Eikelboom
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

7.  Feeding specific glutamate surge in the rat lateral hypothalamus revealed by low-flow push-pull perfusion.

Authors:  Kongthong Thongkhao-on; David Wirtshafter; Scott A Shippy
Journal:  Pharmacol Biochem Behav       Date:  2008-02-21       Impact factor: 3.533

Review 8.  Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: A meta-analysis of prospective studies.

Authors:  Mislav Vrsalović; Ana Vrsalović Presečki
Journal:  Clin Cardiol       Date:  2017-12-15       Impact factor: 2.882

9.  Atrial Fibrillation Predicts Cardiovascular Outcome in Hypertensive Patients With Symptomatic Peripheral Artery Disease and Preserved Ejection Fraction.

Authors:  Mislav Vrsalovic; Ksenija Vucur; Bojan Jelakovic
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-14       Impact factor: 3.738

10.  The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database.

Authors:  Jaime Caro; Kristen Migliaccio-Walle; Khajak J Ishak; Irina Proskorovsky
Journal:  BMC Cardiovasc Disord       Date:  2005-06-22       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.